Literature DB >> 12930370

Hypogalactosylation of serum IgG in patients with coeliac disease.

J A Cremata1, L Sorell, R Montesino, R Garcia, M Mata, G Cabrera, J A Galvan, G Garcia, R Valdes, J A Garrote.   

Abstract

Coeliac disease (CD) is described as an autoimmune enteropathy associated with the presence of IgG and IgA antigliadin and antitransglutaminase autoantibodies. While of diagnostic significance, the role of these autoantibodies in the immunopathogenesis of CD is elucidated. An inappropriate T cell immune response to gluten is also involved in the pathogenesis of CD, as evidenced by autoantibody switching. The N-glycans released from serum IgG of CD patients and three groups of healthy controls, of differing age ranges, were analysed by NH2-high performance liquid chromatography (HPLC). The fucosylated biantennary N- glycans were the most abundant neutral oligosaccharides; in particular, the agalacto form (G0F) showed a mean value of 42% (s.d. +/- 7.4), 30% (s.d. +/- 5.9), 26% (s.d. +/- 4.2) and 35% (s.d. +/- 6.8) for CD patients, healthy children, healthy adults under 40 and healthy adults over 40 years old, respectively. The ratio of asialo agalacto fucosylated biantenna to asialo monogalacto fucosylated biantenna (G0F)/(G1F) for CD patients showed a significant increase compared to healthy children (P < 0.0002), healthy adults under 40 (P < 0.0002) and healthy adults over 40 years old (P < 0.01). Hypogalactosylation was more pronounced for CD patients than for the patients with other autoimmune diseases such as rheumatoid arthritis or psoriatic arthritis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930370      PMCID: PMC1808795          DOI: 10.1046/j.1365-2249.2003.02220.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Celiac disease and its link to type 1 diabetes mellitus.

Authors:  D Schuppan; E G Hahn
Journal:  J Pediatr Endocrinol Metab       Date:  2001       Impact factor: 1.634

Review 3.  Celiac disease: the past, the present, the future.

Authors:  A Fasano
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

4.  Celiac disease in children with autoimmune thyroid disease.

Authors:  D Larizza; V Calcaterra; C De Giacomo; A De Silvestri; M Asti; C Badulli; M Autelli; E Coslovich; M Martinetti
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

Review 5.  Celiac disease--a worldwide problem.

Authors:  K Horvath; D I Mehta
Journal:  Indian J Pediatr       Date:  2000-10       Impact factor: 1.967

6.  Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells.

Authors:  X Dong; W J Storkus; R D Salter
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

7.  Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.

Authors:  Y Mimura; P Sondermann; R Ghirlando; J Lund; S P Young; M Goodall; R Jefferis
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

8.  Human IgA activates the complement system via the mannan-binding lectin pathway.

Authors:  A Roos; L H Bouwman; D J van Gijlswijk-Janssen; M C Faber-Krol; G L Stahl; M R Daha
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 9.  Current concepts of celiac disease pathogenesis.

Authors:  D Schuppan
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

10.  High-performance liquid chromatographic profiling of fluorescent labelled N-glycans on glycoproteins.

Authors:  C-T Yuen; C K Gee; C Jones
Journal:  Biomed Chromatogr       Date:  2002-06       Impact factor: 1.902

View more
  3 in total

1.  Galactosylation of serum IgA1 O-glycans in celiac disease.

Authors:  Katri Lindfors; Hitoshi Suzuki; Jan Novak; Pekka Collin; Päivi Saavalainen; Lotta L E Koskinen; Markku Mäki; Katri Kaukinen
Journal:  J Clin Immunol       Date:  2010-10-12       Impact factor: 8.317

Review 2.  Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.

Authors:  Konstantinos Flevaris; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

3.  Effects of allergic diseases and age on the composition of serum IgG glycome in children.

Authors:  Marija Pezer; Jerko Stambuk; Marija Perica; Genadij Razdorov; Ivana Banic; Frano Vuckovic; Adrijana Miletic Gospic; Ivo Ugrina; Ana Vecenaj; Maja Pucic Bakovic; Sandra Bulat Lokas; Jelena Zivkovic; Davor Plavec; Graham Devereux; Mirjana Turkalj; Gordan Lauc
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.